See All Slides - tctmd.com

Slides

Presentation ESC 2025

BETAMI-DANBLOCK: Randomized Discontinuation of Beta-blockers After Myocardial Infarction in Patients Without Heart Failure

Presenter: Eva Prescott, Dan Atar

August 30, 2025

Presentation ESC 2025

Essence-TIMI 73b: Olezarsen in patients with hypertriglyceridemia at high cardiovascular risk

Presenter: Brian Bergmark

August 30, 2025

Presentation ESC 2025

Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction: REBOOT

Presenter: Borja Ibanez

August 30, 2025

Presentation ESC 2025

DANCAVAS 2: Screening and intervention to prevent cardiovascular disease and death

Presenter: Axel Diederichsen

August 30, 2025

Presentation ESC 2025

AQUATIC: Assessment of Quitting versus Using Aspirin Therapy In patients with stabilized Coronary artery disease after stenting who require long-term oral anticoagulation

Presenter: Martine Gilard

August 30, 2025

Presentation ESC 2025

PercutaNEOus Coronary Intervention Followed by Monotherapy INstead of Dual Antiplatelet Therapy in the SETting of Acute Coronary Syndromes: The NEO-MINDSET trial

Presenter: Pedro A. Lemos

August 30, 2025

Presentation ESC 2025

Mavacamten in Symptomatic Nonobstructive Cardiomyopathy: Primary results of the ODYSSEY-HCM Trial

Presenter: Milind Y Desai

August 30, 2025

Presentation ESC 2025

AMALFI: Active Monitoring for Atrial Fibrillation: A randomized controlled trial of remote screening for asymptomatic atrial fibrillation

Presenter: Rohan Wijesurendra

August 29, 2025

Presentation ESC 2025

DOUBLE-CHOICE: A 2x2 Randomized Trial of Peri-interventional Anesthesia Strategies and Self-Expanding Valve Types in Patients Undergoing Transcatheter Aortic Valve Implantation

Presenter: Mohamed Abdel-Wahab

August 29, 2025

Presentation ESC 2025

POTCAST: A Randomized Controlled Trial Showing Arrhythmia Prevention Using Targeted Plasma Potassium Levels in ICD Patients

Presenter: Henning Bundgaard

August 29, 2025

Advertisement

Slides

BETAMI-DANBLOCK: Randomized Discontinuation of Beta-blockers After Myocardial Infarction in Patients Without Heart Failure

Essence-TIMI 73b: Olezarsen in patients with hypertriglyceridemia at high cardiovascular risk

Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction: REBOOT

DANCAVAS 2: Screening and intervention to prevent cardiovascular disease and death

AQUATIC: Assessment of Quitting versus Using Aspirin Therapy In patients with stabilized Coronary artery disease after stenting who require long-term oral anticoagulation

PercutaNEOus Coronary Intervention Followed by Monotherapy INstead of Dual Antiplatelet Therapy in the SETting of Acute Coronary Syndromes: The NEO-MINDSET trial

Mavacamten in Symptomatic Nonobstructive Cardiomyopathy: Primary results of the ODYSSEY-HCM Trial

AMALFI: Active Monitoring for Atrial Fibrillation: A randomized controlled trial of remote screening for asymptomatic atrial fibrillation

DOUBLE-CHOICE: A 2x2 Randomized Trial of Peri-interventional Anesthesia Strategies and Self-Expanding Valve Types in Patients Undergoing Transcatheter Aortic Valve Implantation

POTCAST: A Randomized Controlled Trial Showing Arrhythmia Prevention Using Targeted Plasma Potassium Levels in ICD Patients

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content